Patients Reap Rewards of Investment in State-of-the-Art Laser Technology by Central Ohio Urology Group
COLUMBUS, Ohio — July 27, 2021
Nearly two years ago, Central Ohio Urology Group (COUG) became the first in Columbus to offer the state-of-the-art MOSES Pulse 120H holmium laser by Lumenis for minimally invasive surgery to remove kidney stones. This week, physicians at COUG are reporting how the introduction of this technology has benefited patients, as well as describing plans to offer the new gold-standard treatment for enlarged prostate, called holmium laser enucleation of the prostate (HoLEP).
“The technology actually enables us to precisely and efficiently ‘dust’ and fragment most ureteral and kidney stones, so patients can go home stone-free.”
“Safety and quality are most important to us, which is why we’ve made it a priority to offer less invasive, faster surgery with the MOSES laser,” said COUG surgeon Dr. Rashmi I. Patel. “The technology actually enables us to precisely and efficiently ‘dust’ and fragment most ureteral and kidney stones, so patients can go home stone-free.”
“Now we’re treating stones with greater safety, efficacy and speed, and we’re excited to report that we’ll soon be bringing the same gold-standard care to enlarged prostate, which affects more than half of men over age 60,1” said COUG urologist Dr. Adam C. Weiser. “HoLEP surgery with the MOSES laser will allow us to treat prostates of any size in a safe, effective, minimally invasive outpatient procedure.”
“Adding the revolutionary MOSES Pulse 120H to COUG has been an important step forward for men’s health in central Ohio,” explained COUG CEO Mark Cherney. “Our surgeons have been able to deliver exceptional clinical outcomes for patients with kidney stones. With the addition of HoLEP for treatment of enlarged prostates, COUG will continue to press forward in our commitment to provide advanced, compassionate care to patients in our region.”
1. Claus G Roehrborn CG. Benign Prostatic Hyperplasia: An Overview. Rev Urol. 2005; 7(Suppl 9): S3–S14.
About Central Ohio Urology Group, LLC
Central Ohio Urology Group, LLC (COUG) is a leading provider of urological services with a network of 15 locations in the region. Headquartered just outside of Columbus in Gahanna, Ohio, COUG provides a comprehensive suite of services, including men’s health, women’s health, cancer care, advanced treatment options for prostate and bladder cancer, and radiation oncology. For more information, visit www.centralohiourology.com.
Mark Cherney, CEO
Central Ohio Urology Group, LLC
Director of Surgical Marketing